Market Research Logo

The Spectranetics Corp (SPNC) - Product Pipeline Analysis, 2017 Update

Summary

The Spectranetics Corp (Spectranetics) is a medical device company that manufactures and distributes disposable medical devices. The company provides vascular intervention, lead management and coronary intervention products. It offers peripheral and cardiac laser catheters for ablation of stenosed and occluded arteries. Spectranetics also offers coronary laser atherectomy catheters, scoring balloon catheter, excimer laser system, extraction catheter and support catheters. The company offers training and support services. It caters to physicians, patients and hospitals. The company operates in the Netherlands, France, Denmark, Germany, Austria, Australia and the UK. Spectranetics is headquartered in Colorado Springs, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company The Spectranetics Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


The Spectranetics Corp Company Overview
The Spectranetics Corp Company Snapshot
The Spectranetics Corp Pipeline Products and Ongoing Clinical Trials Overview
The Spectranetics Corp – Pipeline Analysis Overview
The Spectranetics Corp - Key Facts
The Spectranetics Corp - Major Products and Services
The Spectranetics Corp Pipeline Products by Development Stage
The Spectranetics Corp Ongoing Clinical Trials by Trial Status
The Spectranetics Corp Pipeline Products Overview
CardioSculpt Valvuloplasty Scoring Balloon
CardioSculpt Valvuloplasty Scoring Balloon Product Overview
Drug Coated Balloon - In-stent Restenosis (ISR)
Drug Coated Balloon - In-stent Restenosis (ISR) Product Overview
Nexcimer
Nexcimer Product Overview
Next Gen Lead Management (LM) Tool
Next Gen Lead Management (LM) Tool Product Overview
Next-Gen Atherectomy Device
Next-Gen Atherectomy Device Product Overview
Next-gen Mechanical Tool
Next-gen Mechanical Tool Product Overview
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK)
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) Product Overview
Stellarex Drug Coated Balloon - Above-The-Knee
Stellarex Drug Coated Balloon - Above-The-Knee Product Overview
Stellarex Drug Coated Balloon - Above-The-Knee Clinical Trial
The Spectranetics Corp - Key Competitors
The Spectranetics Corp - Key Employees
The Spectranetics Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
The Spectranetics Corp, Recent Developments
Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors
Apr 27, 2017: Spectranetics Reports First Quarter 2017 Revenue of $69.7 million
Feb 23, 2017: Spectranetics Reports Fourth Quarter 2016 Revenue of $71.9 million
Jan 24, 2017: ILLUMENATE Global 12-month Results Validate Stellarex’s Top-tier Performance in Complex Patient Populations
Jan 11, 2017: Spectranetics Names Scott Hutton as General Manager, Vascular Intervention
Nov 21, 2016: Spectranetics Receives CE Mark for Stellarex 0.014” Drug-Coated Balloon
Nov 02, 2016: Stellarex ILLUMENATE Pivotal Results Are Top-tier in the Most Complex Patient Group Studied in DCB IDE Trials
Nov 02, 2016: Spectranetics Files PMA Application for FDA Approval of the Stellarex Drug-Coated Balloon
Oct 27, 2016: Spectranetics Reports Third Quarter 2016 Revenue of $68.3 million
Aug 10, 2016: First Randomized Trial of the Stellarex Drug-coated Balloon Presented at the Amputation Prevention Symposium
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
The Spectranetics Corp Pipeline Products and Ongoing Clinical Trials Overview
The Spectranetics Corp Pipeline Products by Equipment Type
The Spectranetics Corp Pipeline Products by Indication
The Spectranetics Corp Ongoing Clinical Trials by Trial Status
The Spectranetics Corp, Key Facts
The Spectranetics Corp, Major Products and Services
The Spectranetics Corp Number of Pipeline Products by Development Stage
The Spectranetics Corp Pipeline Products Summary by Development Stage
The Spectranetics Corp Ongoing Clinical Trials by Trial Status
The Spectranetics Corp Ongoing Clinical Trials Summary
CardioSculpt Valvuloplasty Scoring Balloon - Product Status
CardioSculpt Valvuloplasty Scoring Balloon - Product Description
Drug Coated Balloon - In-stent Restenosis (ISR) - Product Status
Drug Coated Balloon - In-stent Restenosis (ISR) - Product Description
Nexcimer - Product Status
Nexcimer - Product Description
Next Gen Lead Management (LM) Tool - Product Status
Next Gen Lead Management (LM) Tool - Product Description
Next-Gen Atherectomy Device - Product Status
Next-Gen Atherectomy Device - Product Description
Next-gen Mechanical Tool - Product Status
Next-gen Mechanical Tool - Product Description
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) - Product Status
Stellarex 0.014” Drug-Coated Balloon - Below The Knee (BTK) - Product Description
Stellarex Drug Coated Balloon - Above-The-Knee - Product Status
Stellarex Drug Coated Balloon - Above-The-Knee - Product Description
Stellarex Drug Coated Balloon - Above-The-Knee - Economic Evaluation Comparing Standard Balloon Angioplasty Versus Drug-eluted Balloon or Laser-excimer in Association with Drug-eluted Balloon in the Treatment of Femoropopliteal Artery In-stent Restenosis
Stellarex Drug Coated Balloon - Above-The-Knee - Prospective, Randomized, Multi-center, Single-blinded Study for the Treatment of Subjects Presenting with De Novo Occluded/Stenotic or Re-occluded/Restenotic Lesions of the Superficial Femoral or Popliteal Arteries Using Paclitaxel or Bare Percutaneous Transluminal Angioplasty Balloon Catheter
Stellarex Drug Coated Balloon - Above-The-Knee - Prospective, Single-arm, Global Multi-center Study to Evaluate Treatment of Obstructive Superficial Femoral Artery (SFA) and/or Popliteal Lesions with a Novel Paclitaxel-coated Percutaneous Angioplasty (PTA) Balloon and in In-Stent Restenosis (ILLUMENATE GLOBAL and ISR)
Stellarex Drug Coated Balloon - Above-The-Knee - Prospective, Single-arm, Multi-center, Pharmacokinetic Study to Evaluate Treatment of Obstructive Superficial Femoral Artery or Popliteal Lesions with a Novel Paclitaxel-coated Percutaneous Angioplasty Balloon
Stellarex Drug Coated Balloon - Above-The-Knee - Stellarex Vascular E-Registry
The Spectranetics Corp, Key Employees
The Spectranetics Corp, Other Locations
The Spectranetics Corp, Subsidiaries
Glossary
List of Figures
The Spectranetics Corp Pipeline Products by Equipment Type
The Spectranetics Corp Pipeline Products by Development Stage
The Spectranetics Corp Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report